Display options
Cite
Sun Y, Liu Z. Response to Philips and Abraham. Am J Gastroenterol. 2021;116(9):1958-1959doi: 10.14309/ajg.0000000000001383.
Sun, Y., & Liu, Z. (2021). Response to Philips and Abraham. The American journal of gastroenterology, 116(9), 1958-1959. https://doi.org/10.14309/ajg.0000000000001383
Sun, Yuanjie, and Liu, Zhishun. "Response to Philips and Abraham." The American journal of gastroenterology vol. 116,9 (2021): 1958-1959. doi: https://doi.org/10.14309/ajg.0000000000001383
Sun Y, Liu Z. Response to Philips and Abraham. Am J Gastroenterol. 2021 Sep 01;116(9):1958-1959. doi: 10.14309/ajg.0000000000001383. PMID: 34264203.
Copy Download .nbib Format: NLM
Share it on

Am J Gastroenterol. 2021 Sep 01;116(9):1958-1959. doi: 10.14309/ajg.0000000000001383.

Response to Philips and Abraham.

The American journal of gastroenterology

Yuanjie Sun, Zhishun Liu

Affiliations

  1. Department of Acupuncture and Moxibustion, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

PMID: 34264203 DOI: 10.14309/ajg.0000000000001383

[No abstract available.]

References

  1. Liu B, Wu J, Yan S, et al. Electroacupuncture vs prucalopride for severe chronic constipation: A multicenter, randomized, controlled, noninferiority trial. Am J Gastroenterol 2021;116:1024–35. - PubMed
  2. Philips CA, Abraham L. Electroacupuncture vs Prucalopride for Severe Chronic Constipation: Aiming for Excellence in Mediocrity? Am J Gastroenterol 2021;116:1957. - PubMed
  3. Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: A randomized trial. Ann Intern Med 2016;165:761–9. - PubMed
  4. Camilleri M, Kerstens R, Rykx A, et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008;358:2344–54. - PubMed
  5. Tack J, van Outryve M, Beyens G, et al. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009;58:357–65. - PubMed
  6. Yiannakou Y, Piessevaux H, Bouchoucha M, et al. A randomized, double blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. Am J Gastroenterol 2015;110:741–8. - PubMed
  7. Luthra P, Camilleri M, Burr NE, et al. Efficacy of drugs in chronic idiopathic constipation: A systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2019;4:831–44. - PubMed
  8. Yang T, Wang K, Cao Y, et al. Different doses of prucalopride in treating chronic idiopathic constipation: A meta-analysis and Bayesian analysis. BMJ Open 2021;11:e039461. - PubMed

Publication Types